302847
Routine HIV Community Testing and Partnerships in High Prevalence Urban Areas
The Bridge Project found that about 50% of clients who tested in the DHS sites were first time testers, a key indication that this community testing partnership was identifying and testing individuals who may not have otherwise tested. Testing by the Bridge Project has also has identified an increased number of positive diagnoses among young men who have sex with men.
In their second year, the partnership implemented a “VIP” linkage to care program. The program provides standing medical appointments and support for patients that are diagnosed with HIV or for DHS clients who have dropped out of care. Linkages to care rates have increased from 52% to 73% since the VIP program began. The Bridge Project has also integrated routine HCV testing to assess whether offering both tests at the same time makes clients more likely to accept an HIV test. Since implementing HCV screening, 508 DHS clients were tested and 18 positives identified (3.5% seropositivity).
Learning Areas:
Public health or related researchLearning Objectives:
Discuss an innovative partnership for providing routine HIV testing in high prevalence areas in a nonclinical setting. Attendees will also learn about an emerging linkage and retention to care program that can be used with nonclinical HIV testing.
Keyword(s): HIV/AIDS, Community-Based Partnership & Collaboration
Qualified on the content I am responsible for because: Cynthia Tucker has been working in prevention for over nineteen years. As the Director of prevention and community partnerships, she coordinates special initiative projects focusing on prevention, case management and leadership development. Formerly she was the director of prevention at Chicago Women’s AIDS Project (CWAP) for over eight years. There she conceptualized new ways for working with African American communities and created programs that are responsive to the epidemic.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.